Company / Profit Margin
TherapeuticsMD, Inc. Profit Margin History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-789.4%
FY2024
5-year range
-6700.9% / 160.1%
FY2020-FY2024
Trend
-593.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin changed -593% YoY in FY2024, a notable deviation from the 9-year average annual change of -260%.
Based on SEC 10-K filings.
-789.4% in FY2024 with a 5-year CAGR of -330.9%.
Improved from -6700.9% to -789.4% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -434.6pp
- 5-Year Change
- -330.9pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, profit margin decreased 593.1% year-over-year.
- Peak profit margin was recorded in FY2023.
- Lowest profit margin in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -789.4% | -593.1% |
| FY2023 | 160.1% | +102.4% |
| FY2022 | -6700.9% | -1788.7% |
| FY2021 | -354.8% | +56.9% |
| FY2020 | -823.7% | -79.7% |
| FY2019 | -458.5% | +1.3% |
| FY2018 | -464.3% | -9.9% |
| FY2017 | -422.4% | -17.1% |
| FY2016 | -360.8% | -11.4% |
| FY2015 | -323.8% | +64.8% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026